Showing results (91-100 of 108) with videos related to
Sort By:
Pageof 11
Mabs|February 23, 2023
Assessing developability early in the discovery process for novel biologicsMonica L Fernández-Quintero, Anne Ljungars, Franz Waibl, et al.The Journal of Experimental Medicine|July 14, 2020
FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex-driven autoimmunityJonathan J Hubbard, Michal Pyzik, Timo Rath, et al.Mabs|April 4, 2022
In silico proof of principle of machine learning-based antibody design at unconstrained scaleRahmad Akbar, Philippe A Robert, Cédric R Weber, et al.Cell Systems|November 13, 2025
Systematic benchmarking of mass spectrometry-based antibody sequencing reveals methodological biasesMaria Chernigovskaya, Khang Lê Quý, Maria Stensland, et al.The Journal of Biological Chemistry|April 13, 2025
Exploiting FcRn engagement of an albumin-CpG oligonucleotide covalent conjugate for potent TLR9 immune inductionDiego Pilati, Eugene Kusi Agyei, Marwa Elkhashab, et al.PNAS Nexus|December 11, 2023
A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal deliverySopisa Benjakul, Aina Karen Anthi, Anette Kolderup, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 21, 2021
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinationsMarton König, Åslaug Rudjord Lorentzen, Hilde Marie Torgauten, et al.Science (New York, N.Y.)|March 30, 2023
Cytosolic antibody receptor TRIM21 is required for effective tau immunotherapy in mouse modelsAamir S Mukadam, Lauren V C Miller, Annabel E Smith, et al.Proceedings of the National Academy of Sciences of the United States of America|March 24, 2017
Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injuryMichal Pyzik, Timo Rath, Timothy T Kuo, et al.Structure (London, England : 1993)|August 15, 2024
Engineering of pH-dependent antigen binding properties for toxin-targeting IgG1 antibodies using light-chain shufflingTulika Tulika, Fulgencio Ruso-Julve, Shirin Ahmadi, et al.Pageof 11